http://www.CLINICell.com "ACL TEAR alternative with PRP and Stem Cell Therapy"

By: ClinicellTech

See more here:
http://www.CLINICell.com "ACL TEAR alternative with PRP and Stem Cell Therapy" - Video

What are bone marrow and hematopoietic stem cells?

Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic or blood-forming stem cells. (Hematopoietic stem cells are different from embryonic stem cells. Embryonic stem cells can develop into every type of cell in the body.) Hematopoietic stem cells divide to form more blood-forming stem cells, or they mature into one of three types of blood cells: white blood cells, which fight infection; red blood cells, which carry oxygen; and platelets, which help the blood to clot. Most hematopoietic stem cells are found in the bone marrow, but some cells, called peripheral blood stem cells (PBSCs), are found in the bloodstream. Blood in the umbilical cord also contains hematopoietic stem cells. Cells from any of these sources can be used in transplants.

What are bone marrow transplantation and peripheral blood stem cell transplantation?

Bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) are procedures that restore stem cells that have been destroyed by high doses of chemotherapy and/or radiation therapy. There are three types of transplants:

Why are BMT and PBSCT used in cancer treatment?

One reason BMT and PBSCT are used in cancer treatment is to make it possible for patients to receive very high doses of chemotherapy and/or radiation therapy. To understand more about why BMT and PBSCT are used, it is helpful to understand how chemotherapy and radiation therapy work.

Chemotherapy and radiation therapy generally affect cells that divide rapidly. They are used to treat cancer because cancer cells divide more often than most healthy cells. However, because bone marrow cells also divide frequently, high-dose treatments can severely damage or destroy the patients bone marrow. Without healthy bone marrow, the patient is no longer able to make the blood cells needed to carry oxygen, fight infection, and prevent bleeding. BMT and PBSCT replace stem cells destroyed by treatment. The healthy, transplanted stem cells can restore the bone marrows ability to produce the blood cells the patient needs.

In some types of leukemia, the graft-versus-tumor (GVT) effect that occurs after allogeneic BMT and PBSCT is crucial to the effectiveness of the treatment. GVT occurs when white blood cells from the donor (the graft) identify the cancer cells that remain in the patients body after the chemotherapy and/or radiation therapy (the tumor) as foreign and attack them. (A potential complication of allogeneic transplants called graft-versus-host disease is discussed in Questions 5 and 14.)

What types of cancer are treated with BMT and PBSCT?

BMT and PBSCT are most commonly used in the treatment of leukemia and lymphoma. They are most effective when the leukemia or lymphoma is in remission (the signs and symptoms of cancer have disappeared). BMT and PBSCT are also used to treat other cancers such as neuroblastoma (cancer that arises in immature nerve cells and affects mostly infants and children) and multiple myeloma. Researchers are evaluating BMT and PBSCT in clinical trials (research studies) for the treatment of various types of cancer.

Read more here:
Bone Marrow Transplantation and Peripheral Blood Stem Cell ...

We stand at the threshold of a new and exciting medicine of Regeneration where transplants of stem cells can potentially restore function to injured, diseased and debilitated tissues and organs.

Embryonic-like stem cells found in umbilical cord blood!

Umbilical cord blood was first used for blood and immune system disorders about 18 years ago.For the past several years, new possibilities for their use in a wider variety of health conditions, genetic disorders and anti-aging treatmentshave beengaining support with various multipotent stem cells and progenitor cells being discovered in the cord blood. In fact, embryonic-like stem cells have actually been found in umbilical cord blood and are beingused in clinical researchnow for various neurological disorders outside the United States. Dr. Colin McGuckin and associates from the U.K. have published preliminary findings on these embryonic-like stem cells.

Whether the health challenge is Alzheimer's Disease, Stroke, Traumatic Brain Injury, Cerebral Palsy, Spinal Cord Injuries, Parkinson's Disease, Heart Disease, Diabetes, Blindness or Immune Deficiencies, the results of preliminary animal and human studies have been very promising.

With each passing year, the field is growing exponentially and we invite you to find out more about this exciting new field of regenerative medicine.

This website is sponsored by the Steenblock Research Institute, a 501(c)(3)California non-profit corporation dedicated to educating the public about safe and effective alternatives for difficult medical cases. Contribute to our on-going projects in researching medical alternatives here.

UMBILICAL CORD STEM CELL THERAPY by David Steenblock, D.O. and Anthony Payne, Ph.D.

This book presents case studies of umbilical cord stem cells being used to treat patients with cancer, cerebral palsy, stroke, ALS, MS and other challenging medical conditions.

Read the original here:
Stem Cell Therapy Research Dr. Steenblock Umbilical Cord Stem ...

Cell therapy (or Cellular therapy) is therapy in which cellular material is injected into a patient.[1]

Cell therapy originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness.[2] Although such attempts produced no positive benefit, further research found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.[3]

Today two distinct categories of cell therapy are recognized.[1]

The first category is cell therapy in mainstream medicine. This is the subject of intense research and the basis of potential therapeutic benefit.[4] Such research, especially when it involves human embryonic material, is controversial.

The second category is in alternative medicine, and perpetuates the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.[1]

Cell therapy can be defined as therapy in which cellular material is injected into a patient.[1]

There are two branches of cell therapy: one is legitimate and established, whereby human cells are transplanted from a donor to a patient; the other is dangerous alternative medicine, whereby injected animal cells are used to attempt to treat illness.[1]

The origins of cell therapy can perhaps be traced to the nineteenth century, when Charles-douard Brown-Squard (18171894) injected animal testicle extracts in an attempt to stop the effects of aging.[2] In 1931 Paul Niehans (18821971) who has been called the inventor of cell therapy attempted to cure a patient by injecting material from calf embryos.[1] Niehans claimed to have treated many people for cancer using this technique, though his claims have never been validated by research.[1]

In 1953 researchers found that laboratory animals could be helped not to reject organ transplants by pre-innoculating them with cells from donor animals; in 1968, in Minnesota, the first successful successful human bone marrow took place.[3]

Bone marrow transplants have been found to be effective, along with some other kinds of human cell therapy for example in treating damaged knee cartilage.[1] In recent times, cell therapy using human material has been recognized as an important field in the treatment of human disease.[4] The experimental field of Stem cell therapy has shown promise for new types of treatment.[1]

See the article here:
Cell therapy - Wikipedia, the free encyclopedia